E. Winton
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in ⓘ
- Hematology 11
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 4
- Genetics 7
- Chronic Lymphocytic Leukemia Research 3
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Leonard T. Heffner (3 shared papers)S P Dix (3 shared papers)John R. Wingard (3 shared papers)H. Kent Holland (3 shared papers)C D Hillyer (3 shared papers)Robert B. Geller (2 shared papers)S M Devine (2 shared papers)C. Gilmore (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)British Journal of Haematology (1 paper)Bone Marrow Transplantation (1 paper)FEBS Letters (1 paper)Leukemia Research (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
E. Winton
23 papers receiving 598 citations
Peers
Comparison fields: 5 of 65
- Hematology 403
- Transplantation 49
- Genetics 88
- Oncology 148
- Public Health, Environmental and Occupational Health 134
Countries citing papers authored by E. Winton
This map shows the geographic impact of E. Winton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Winton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Winton more than expected).
Fields of papers citing papers by E. Winton
This network shows the impact of papers produced by E. Winton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Winton. The network helps show where E. Winton may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Winton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Association of busulfan area under the curve with veno-occlusive disease following BMT. | 1996 | 262 |
| 2 | 1996 | 47 | |
| 3 | Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide. | 1987 | 40 |
| 4 | The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. | 1997 | 31 |
| 5 | 1990 | 23 | |
| 6 | Recombinant human granulocyte-macrophage colony-stimulating factor promotes megakaryocyte maturation in nonhuman primates. | 1991 | 22 |
| 7 | 1989 | 22 | |
| 8 | 1975 | 18 | |
| 9 | Phase II clinical trial of carboplatin in relapsed and refractory leukemia. | 1992 | 18 |
| 10 | Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia. | 1981 | 16 |
| 11 | 2008 | 13 | |
| 12 | Preliminary results of a multicenter trial to prevent death from cytomegalovirus pneumonia with intravenous immunoglobulin after allogeneic bone marrow transplantation. | 1987 | 13 |
| 13 | 1992 | 13 | |
| 14 | 1995 | 10 | |
| 15 | 1996 | 9 | |
| 16 | Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group. | 1985 | 9 |
| 17 | Therapeutic activity of 1-beta-D-arabinofuranosylcytosine conjugates of lipids in WEHI-3B leukemia in mice. | 1989 | 9 |
| 18 | Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation. | 1989 | 7 |
| 19 | 2019 | 7 | |
| 20 | 1985 | 7 |
About E. Winton
E. Winton is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Immunology, having authored 23 papers that have together received 608 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Cancer Treatment and Pharmacology (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Hematology (403 citations), Transplantation (49 citations), Genetics (88 citations), Oncology (148 citations) and Public Health, Environmental and Occupational Health (134 citations). E. Winton has collaborated with scholars based in United States and Canada. Frequent co-authors include Leonard T. Heffner, S P Dix, John R. Wingard, H. Kent Holland, C D Hillyer, Robert B. Geller, S M Devine, C. Gilmore, Rein Saral and Richard E. Mullins. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation, FEBS Letters and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.